SCHEMBL2804150

SCHEMBL2804150

Fc1ccc(C2Cc3cnc(Nc4ccc5[nH]ccc5c4)nc3-c3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.46
FGFR2 P21802 2/20 0.46
FGFR3 P22607 2/20 0.46
CSF1R P07333 1/20 0.46
ULK1 O75385 3/20 0.43
EGFR P00533 6/20 0.42
PLK2 Q9NYY3 3/20 0.42
LCK P06239 1/20 0.42
KIT P10721 1/20 0.42
FLT3 P36888 1/20 0.42
PLK1 P53350 1/20 0.42
RPS6KA1 Q15418 1/20 0.42
PIM3 Q86V86 1/20 0.42
WNK2 Q9Y3S1 1/20 0.42
SYK P43405 3/20 0.41
WEE1 P30291 1/20 0.40
KDR P35968 1/20 0.40
NEK2 P51955 1/20 0.39
NEK5 Q6P3R8 1/20 0.39
NEK1 Q96PY6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802868 0.93 FGFR1 (0.52) FGFR1FGFR2FGFR3CSF1RULK1
SCHEMBL13126212 0.91 WEE1 (0.46) FGFR1FGFR2FGFR3CSF1RULK1
SCHEMBL2807843 0.85 WEE1 (0.49) FGFR1FGFR2FGFR3CSF1RULK1
SCHEMBL2804947 0.84 FGFR1 (0.56) FGFR1FGFR2FGFR3CSF1REGFR
SCHEMBL2806613 0.80 FGFR1 (0.47) FGFR1FGFR2FGFR3CSF1RPLK1
SCHEMBL13126189 0.79 FGFR1 (0.51) FGFR1FGFR2FGFR3CSF1RULK1
SCHEMBL2802708 0.78 FGFR1 (0.49) FGFR1FGFR2FGFR3CSF1RKDR
SCHEMBL2803788 0.78 KDR (0.53) FGFR1FGFR2FGFR3CSF1REGFR
SCHEMBL2802779 0.77 KDR (0.48) FGFR1FGFR2FGFR3CSF1REGFR
SCHEMBL2802428 0.77 FGFR1 (0.50) FGFR1FGFR2FGFR3CSF1RKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885FGFR3 521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.